Eunkyung Bae
Overview
Explore the profile of Eunkyung Bae including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
1744
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu S, Wu K, Wang Y, Bae E, Chianelli F, Bambakidis N, et al.
BMC Neurosci
. 2024 Oct;
25(1):49.
PMID: 39379834
Background: Psilocybin is a psychedelic 5HT2A receptor agonist found in "magic mushrooms". Recent studies have indicated that 5HT2A agonists, such as dimethyltryptamine, given before middle cerebral artery occlusion (MCAo), improve...
2.
Lee H, Jin S, Kim S, Kim J, Kim H, Bae E, et al.
Healthcare (Basel)
. 2024 Jan;
12(1).
PMID: 38200913
In this study, we developed an AI-based real-time motion feedback system for patients with spinal cord injury (SCI) during rehabilitation, aiming to enhance their interest and motivation. The effectiveness of...
3.
Yu S, Wu K, Wang Y, Song J, Wu C, Jan J, et al.
Int J Mol Sci
. 2020 Sep;
21(19).
PMID: 32992950
Intracerebral hemorrhage (ICH) is a major cause of stroke, with high mortality and morbidity. There is no effective pharmacological therapy for ICH. Previous studies have indicated that CXCR4 antagonists reduced...
4.
Yu S, Wu K, Bae E, Wang Y, Chiang C, Kuo L, et al.
iScience
. 2020 Feb;
23(2):100866.
PMID: 32058974
Acetylcholinesterase (AChE) inhibitors have protective and anti-inflammatory actions against brain injury, mediated by nicotinic α7 cholinergic receptor activation. The use of AChE inhibitors in patients is limited by systemic cholinergic...
5.
Chen Y, Bae E, Chen H, Yu S, Harvey B, Greig N, et al.
Neurotox Res
. 2019 May;
36(2):347-356.
PMID: 31069753
Methamphetamine (Meth) is a widely abused stimulant. High-dose Meth induces degeneration of dopaminergic neurons through p53-mediated apoptosis. A recent study indicated that treatment with the p53 inhibitor, pifithrin-alpha (PFT-α), antagonized...
6.
Yu S, Tajiri N, Franzese N, Franzblau M, Bae E, Platt S, et al.
PLoS One
. 2013 Oct;
8(9):e76329.
PMID: 24086730
In this study, we investigated the dog placenta as a viable source of stem cells for stroke therapy. Immunocytochemical evaluation of phenotypic markers of dog placenta cells (DPCs) cultured in...
7.
He Y, Yu S, Bae E, Shen H, Wang Y
Neurotoxicology
. 2013 Sep;
39:138-45.
PMID: 24042092
The nigrostriatal dopaminergic system is a major lesion target for methamphetamine (MA), one of the most addictive and neurotoxic drugs of abuse. High doses of MA alter the expression of...
8.
Reiner D, Yu S, Shen H, He Y, Bae E, Wang Y
Neurotox Res
. 2013 Jul;
25(3):248-61.
PMID: 23884514
Methamphetamine (MA) is a drug of abuse as well as a dopaminergic neurotoxin. 9-Cis retinoic acid (9cRA), a biologically active derivative of vitamin A, has protective effects against damage caused...
9.
Kaneko Y, Tajiri N, Yu S, Hayashi T, Stahl C, Bae E, et al.
Cell Med
. 2012 Oct;
4(2):55-63.
PMID: 23101029
Our understanding of biological mechanisms and treatment options for traumatic brain injury (TBI) is limited. Here, we employed quantitative real-time PCR (QRT-PCR) and immunohistochemical analyses to determine the dynamic expression...
10.
Yin L, Shen H, Diaz-Ruiz O, Backman C, Bae E, Yu S, et al.
BMC Neurosci
. 2012 Oct;
13:120.
PMID: 23040108
Background: Retinoic acid (RA) is a biologically active derivative of vitamin A. Previous studies have demonstrated that RA has protective effects against damage caused by H2O2 or oxygen-glucose deprivation in...